Company

ImPact Biotech

Biotechnology Research Ness Ziona, Il 40 employees

Employees: 40
Contacts: 4
Emails: 4
Phones: 1

www.stebabiotech.com LinkedIn Crunchbase

ImPact Biotech Overview

Headquarters: Ness Ziona, Il
Website: www.stebabiotech.com
Industry: Biotechnology Research
Employees: 40
Founded: 2022
Funding: 12.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About ImPact Biotech

ImPact Biotech is focused on the development and launch of Padeliporfin VTP (Vascular Targeted Photodynamic) therapy for the treatment of solid tumors. The company is headquartered in Israel, with presence in Luxembourg, France and USA, as well as its own GMP-certified (Good Manufacturing Practice) facility and research center in Israel. ImPact Biotech holds exclusive rights from the Weizmann Institute of Science (WIS, Israel) and Memorial Sloan Kettering Cancer Center (MSKCC, New York), to develop and commercialize drugs and related technologies used in VTP.

ImPact Biotech Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 1; 25.0% coverage

ImPact Biotech Org Chart

Sample employees and titles

Name	Title	Location	Contact
Roei Sella	CFO - Global Biotech - Ipo, M	Tel Aviv District, Israel	Email
Orit Schwartz	VP, Head of Global Technical Operations	Kfar Hess, Center District, Israel	Email
Mira Mishiyev	Global Procurement Manager - "Impact	Israel	Email
Dean Kilby	Health-tech Innovations Consultant	Sydney, New South Wales, Australia	Email Phone